1. Home
  2. MAN vs GENB Comparison

MAN vs GENB Comparison

Compare MAN & GENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ManpowerGroup

MAN

ManpowerGroup

HOLD

Current Price

$30.40

Market Cap

1.4B

ML Signal

HOLD

GENB

Generate Biomedicines Inc. Common Stock

N/A

Current Price

$13.32

Market Cap

1.7B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
MAN
GENB
Founded
1948
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.7B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
MAN
GENB
Price
$30.40
$13.32
Analyst Decision
Hold
Strong Buy
Analyst Count
6
6
Target Price
$35.67
$23.20
AVG Volume (30 Days)
1.2M
315.7K
Earning Date
04-16-2026
05-11-2026
Dividend Yield
4.89%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$17,957,100,000.00
N/A
Revenue This Year
$5.12
N/A
Revenue Next Year
$3.42
$16.58
P/E Ratio
N/A
N/A
Revenue Growth
0.58
N/A
52 Week Low
$25.15
$11.00
52 Week High
$47.34
$14.21

Technical Indicators

Market Signals
Indicator
MAN
GENB
Relative Strength Index (RSI) 54.35 55.60
Support Level $28.76 $11.39
Resistance Level $30.40 $13.40
Average True Range (ATR) 1.91 0.68
MACD 0.02 0.08
Stochastic Oscillator 60.43 85.96

Price Performance

Historical Comparison
MAN
GENB

About MAN ManpowerGroup

ManpowerGroup Inc provides workforce solutions and services, including recruitment and assessment, upskilling, reskilling, training and development, career management, outsourcing, and workforce consulting. The company leverages its trusted brands, industry knowledge, and AI-enabled assessments and offers an extensive portfolio of training and leadership development solutions. Its reportable segments are Staffing and Interim, Outcome-Based Solutions and Consulting, Permanent Recruitment, and Others, with Staffing and Interim generating the majority of revenue. It operates in the Americas, Southern Europe, Northern Europe, and APME. The company derives the maximum geographical revenue from the Southern European region.

About GENB Generate Biomedicines Inc. Common Stock

Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.

Share on Social Networks: